Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

April 10, 2024

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

January 20, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

October 18, 2020

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

November 22, 2019

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

September 23, 2015

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

August 12, 2013

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

June 28, 2013

News Daily News

La 1ª Estrategia ATP es Igual que la Implantación Primaria de un Stent en el Tratamiento de la Enfermedad de la Arteria Poplítea

June 28, 2013

News Daily News

La Terapia Endovascular es Prometedora contra la Isquemia Crítica de las Extremidades

February 07, 2013

News Daily News

Endovascular Therapy Promising for Critical Limb Ischemia

February 07, 2013

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

March 08, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.